WinstonWınston
Back
Verano Holdings logo

Verano Holdings

VRNO
29
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$6.21
+0.23 (+3.85%)
Market Cap
$459.0M
Exchange
Other OTC
Winston Score
29
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+25.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 58.1M (2021) → 72.6M (2025)

Winston Score History

The full picture

Verano Holdings is a cannabis company that grows, makes, and sells marijuana products across the United States. Its products include flower, edibles, vapes, and concentrates sold under brand names like Verano, Encore, and MÜV. It sells directly to consumers through its own retail dispensaries and also supplies other licensed cannabis stores.

Verano makes most of its money by selling cannabis products at its own dispensaries, which cuts out the middleman and helps protect its margins. The company operates in more than a dozen US states, with a focus on limited-license markets where regulators cap the number of competitors allowed — that restriction acts as a partial moat. With a market cap around $400 million, it is a mid-sized player in a fragmented industry. The biggest risk Verano faces is that cannabis remains federally illegal in the US, which blocks access to normal banking, raises taxes under IRS Section 280E, and limits the company's ability to grow cheaply.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.0% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+33.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

11.2%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$85M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Verano Holdings is growing revenue at 5% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
46.9%
Healthy — 46.9% gross margin
Profit after running costs
Operating Margin
3.3%
Thin — 3.3% operating margin
Return on the money invested
ROCE
5.1%
Weak — 5.1% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-0.6%
Shrinking sales (-0.6% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
5.4%
Thin free cash flow (5.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.58
Conservative — low debt load (0.58)
Covers its interest
Interest Cover
1.12x
Dangerous — barely covers interest (1.1x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial